Literature DB >> 7654871

New polyurethane compositions able to bond high amounts of both albumin and heparin. Part I.

W Marconi1, A Galloppa, A Martinelli, A Piozzi.   

Abstract

In order to prepare polymers provided with better haemocompatibility with respect both to the coagulative cascade and to platelet aggregation and activation, we have synthesized new polyurethanes containing in the chain-extender [di(2-hydroxyethyl)hexadecylamine] both a long chain alkyl group (able to bond albumin) and a tertiary ammonium group able, after suitable quaternization reaction, to bind ionically significant amounts of heparin. The amounts of heparin and albumin bonded to the polymer films were determined spectrophotometrically. A biological in vitro evaluation of the heparinized and albuminized films was also carried out with respect to blood coagulation factors (by activated partial thromboplastin time measurements) and to platelet adhesion and activation (by platelet count and scanning electron microscopy examination). It was seen that the type of adsorption sequence for albumin and heparin, respectively, onto the various homo- and copolymer films, plays an important role on their biological properties; the possible mechanisms involved are also discussed on the basis of X-ray photoelectron spectroscopy and attenuated transmission reflectance evaluation of the polymer surfaces.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654871     DOI: 10.1016/0142-9612(95)98817-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  2 in total

1.  In vivo histocompatibility evaluation of polyurethane membrane modified by superfine silk-fibroin powder.

Authors:  Chenxi Ouyang; Haiye Xu; Weici Wang; Hongjun Yang; Weilin Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

2.  Adsorptive properties of albumin, fibrinogen, and gamma-globulin on fluorinated diamond-like carbon films coated on PTFE.

Authors:  K Ozeki; I Nagashima; K K Hirakuri; T Masuzawa
Journal:  J Mater Sci Mater Med       Date:  2010-01-26       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.